New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
06:21 EDTVRX, GS, AGN, SHPG, ABBVShire hires Goldman as it confronts takeover offer, NY Times reports
Shire (SHPG) has hired Goldman Sachs (GS) as an adviser as it looks to fend off a takeover offer, the New York Times reports, citing sources. Shire recently rejected a $46B bid from AbbVie (ABBV), and Allergan (AGN), which is fending off takeover offers from Valeant (VRX), has been rumored as a potential bidder for Shire. Reference Link
News For SHPG;GS;ABBV;AGN;VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 16, 2015
07:38 EDTGSGoldman Sachs 'encouraged' about prospects for continued growth
“We are pleased with our results this quarter and the fact that all of our major businesses contributed,” said Lloyd C. Blankfein, Chairman and CEO. “Given more normalized markets and higher levels of client activity, we remain encouraged about the prospects for continued growth.”
07:38 EDTGSGoldman Sachs reports Q1 investment banking revenue up 7% to 1.91B
Subscribe for More Information
07:38 EDTGSGoldman Sachs reports Common Equity Tier 1 ratio 11.4% at March 31
Subscribe for More Information
07:37 EDTGSGoldman Sachs increases quarterly dividend to 65c per share
Subscribe for More Information
07:36 EDTGSGoldman Sachs reports Q1 EPS $5.94, consensus $4.26
Subscribe for More Information
07:19 EDTGSOptions expected to be active: NFLX SNDK UNH PNRA C GS SLB
April 15, 2015
19:08 EDTABBVEnanta confirms AbbVie hepatitis C treatment granted priority review in Japan
Subscribe for More Information
19:03 EDTABBVAbbVie's chronic hepatitis C treatment granted priority review in Japan
Subscribe for More Information
15:59 EDTGSVIX methodology for Goldman Sachs down 1.8% to 20.75 into Q1
Subscribe for More Information
15:57 EDTGSGoldman Sachs April 200 straddle priced for 2.1% movement into Q1
Subscribe for More Information
14:42 EDTGSEarnings Watch: Goldman to report amid optimism on fixed income, trading
Goldman Sachs (GS) is scheduled to report first quarter earnings before the open on Wednesday, April 16, with a conference call scheduled for 9:30 am ET. Goldman is an investment bank. EXPECTATIONS: Analysts are looking for earnings per share of $4.26 on revenue of $9.35B, according to First Call. The consensus range for EPS is $4.11-$4.44 on revenue of $8.72B-$9.65B. LAST QUARTER: Goldman reported higher than expected fourth quarter profits and revenue. However, the revenue of its investment banking and institutional client services businesses fell 16% and 8% respectively versus the same period a year earlier, while the revenue of its fixed income business tumbled 19% year-over-year. In March, Goldman passed the Fed's stress test, and it raised its quarterly dividend by 5c to 65c per share. In April, Reuters reported that Global investment banking fees dropped 8% to $20B in the first quarter, representing the weakest start to the year for the fees since 2012, according to Reuters. Deal activity in Europe, Asia Pacific, and Japan was weak during the quarter, the news service stated. On a positive note for Goldman investors, The Wall Street Journal on April 2 quoted NAB Research and Deutsche Bank as saying that volatility in the currency market had risen 18% from January to mid-March, which should boost profitability for the fixed-income trading businesses at major banks. PEER RESULTS: Perhaps boding well for Goldman, JPMorgan reported on Monday that its Q1 gross investment banking revenue from its commercial banking clients had soared 68%, STREET RESEARCH: On April 7, research firm Susquehanna raised its Q1 EPS estimate for Goldman to $4.24 from $3.60, citing improved trading and fixed income forecasts. The firm increased its price target on the shares to $198 from $190 and set a Neutral rating on the shares. PRICE ACTION: Goldman's stock has jumped almost 13% over the last three months and almost 30% over the last year.
06:11 EDTGSRegulators seek to end 'too big to fail' firms, WSJ reports
Subscribe for More Information
April 14, 2015
14:05 EDTGSGoldman Sachs April volatility elevated into Q1 and outlook
Subscribe for More Information
April 13, 2015
14:07 EDTABBVEarnings Watch: Johnson & Johnson shares down slightly since last earnings
Subscribe for More Information
10:00 EDTABBVOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:42 EDTGSPandora rises after Spotify reportedly valued above $8B in fundraising
Subscribe for More Information
08:34 EDTABBVAbbVie upgraded on Imbruvica outlook at BMO Capital
Subscribe for More Information
07:20 EDTSHPGShire price target raised to $288 from $267 at JPMorgan
JPMorgan raised its price target for Shire to $288 after lifting its estimates for Lifitegrast in dry eye following the FDA's Priority Review designation. The firm believes the FDA is very likely to approve the application in October of this year, without waiting for the third Phase III study late 2015. It upped its 2020 Lifitegrast forecasts by $600M to $900M and reiterates an Overweight rating on Shire.
07:02 EDTABBVAbbVie upgraded to Outperform from Market Perform at BMO Capital
06:39 EDTGSGoldman Sachs in talks to sell NPL business of Archon to D.E. Shaw, Reuters says
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use